GLUT-1 immunoexpression in oral epithelial dysplasia, oral squamous cell carcinoma, and verrucous carcinoma

Journal of Oral Science

Volumn 57, Issue 2, 2015, Pages 115-122

  Angadi, Vidya C ^a   Angadi, Punnya V ^a  

^a KLE VK Institute of Dental Sciences and Hospital   (India)

Author keywords

Glucose transport; GLUT 1; Histologic differentiation; Oral epithelial dysplasia; Oral squamous cell carcinoma; Verrucous carcinoma

Indexed keywords

GLUCOSE TRANSPORTER 1;

EPITHELIUM; GENETICS; HUMAN; METABOLISM; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; VERRUCOUS CARCINOMA;

CARCINOMA, VERRUCOUS; EPITHELIUM; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MOUTH MUCOSA; MOUTH NEOPLASMS;

EID: 85011706246     PISSN: 13434934     EISSN: 18804926     Source Type: Journal    
DOI: 10.2334/josnusd.57.115     Document Type: Article

References (23)

1. Jin X, Lu S, Xing X, Wang L, Mu D, He M et al. (2013) Thalidomide: features and potential significance in oral precancerous conditions and oral cancer. J Oral Pathol Med 42, 355-362.
2. Tilakaratne WM, Sherriff M, Morgan PR, Odell EW (2011) Grading oral epithelial dysplasia: analysis of individual features. J Oral Pathol Med 40, 533-540.
3. Napier SS, Speight PM (2008) Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 37, 1-10.
4. van der Waal I (2009) Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 45, 317-323.
5. Chaudhary M, Gadbail AR, Vidhale G, Mankar Gadbail MP, Gondivkar SM, Gawande M et al. (2012) Comparison of myofibroblasts expression in oral squamous cell carcinoma, verrucous carcinoma, high risk epithelial dysplasia, low risk epithelial dysplasia and normal oral mucosa. Head Neck Pathol 6, 305-313.
6. Carvalho KC, Cunha IW, Rocha RM, Ayala FR, Cajaíba MM, Begnami MD et al. (2011) GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker. Clinics (Sao Paulo) 66, 965-972.
7. Kunkel M, Reichert TE, Benz P, Lehr HA, Jeong JH, Wieand S et al. (2003) Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 97, 1015-1024.
8. Ohba S, Fujii H, Ito S, Fujimaki M, Matsumoto F, Furukawa M et al. (2010) Overexpression of GLUT-1 in the invasion front is associated with depth of oral squamous cell carcinoma and prognosis. J Oral Pathol Med 39, 74-78.
9. Eckert AW, Lautner MH, Schütze A, Taubert H, Schubert J, Bilkenroth U (2011) Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients. Histopathology 58, 1136-1147.
10. Barnes L, Eveson JW, Reichart P, Sidransky D (2005) WHO classification of tumours. Pathology and genetics of head and neck tumours. IARC Press, Lyon, 177-179.
11. Rajendran R, Sivapathasundaram B (2009) Shafer's textbook of oral pathology. 6th ed, Elsevier, 106-107.
12. Jonathan RA, Wijffels KI, Peeters W, de Wilde PC, Marres HA, Merkx MA et al. (2006) The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON. Radiother Oncol 79, 288-297.
13. Reisser C, Eichhorn K, Herold-Mende C, Born AI, Bannasch P (1999) Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck. Int J Cancer 80, 194-198.
14. Rudlowski C, Becker AJ, Schroder W, Rath W, Büttner R, Moser M (2003) GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer. Am J Clin Pathol 120, 691-698.
15. Mendez LE, Manci N, Cantuaria G, Gomez-Marin O, Penalver M, Braunschweiger P et al. (2002) Expression of glucose transporter-1 in cervical cancer and its precursors. Gynecol Oncol 86, 138-143.
16. Ayala FR, Rocha RM, Carvalho KC, Carvalho AL, da Cunha IW, Lourenço SV et al. (2010) GLUT1 and GLUT3 as potential prognostic markers for oral squamous cell carcinoma. Molecules 15, 2374-2387.
17. Cooper R, Sarioğlu S, Sökmen S, Füzün M, Küpelioğlu A, Valentine H et al. (2003) Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma? Br J Cancer 89, 870-876.
18. 18F-FDG uptake on PET in oral cancer. J Korean Assoc Oral Maxillofac Surg 38, 212-220.
19. Haber RS, Rathan A, Weiser KR, Pritsker A, Itzkowitz SH, Bodian C et al. (1998) GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 83, 34-40.
20. Brown RS, Goodman TM, Zasadny KR, Greenson JK, Wahl RL (2002) Expression of hexokinase II and Glut-1 in untreated human breast cancer. Nucl Med Biol 29, 443-453.
21. Smeland E, Kilvaer TK, Sorbye S, Valkov A, Andersen S, Bremnes RM et al. (2012) Prognostic impacts of hypoxic markers in soft tissue sarcoma. Sarcoma 2012, 541650.
22. Kunkel M, Moergel M, Stockinger M, Jeong JH, Fritz G, Lehr HA et al. (2007) Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity. Oral Oncol 43, 796-803.
23. Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, Patterson A et al. (2001) Glucose transporter Glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res 7, 928-934.